UroGen is a biopharmaceutical company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated because patients deserve better options. Our vision to pioneer new treatments is grounded in our innovative drug delivery technology platform RTGel™, our promising pipeline and a collaborative drive for bold results.